{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T21:16:06Z","timestamp":1788988566659,"version":"build-2803163510"},"reference-count":78,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["MOP-82692"],"award-info":[{"award-number":["MOP-82692"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.jsbmb.2017.09.021","type":"journal-article","created":{"date-parts":[[2017,10,2]],"date-time":"2017-10-02T12:17:27Z","timestamp":1506946647000},"page":"242-256","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Effect of the 5\u03b1-reductase enzyme inhibitor dutasteride in the brain of intact and parkinsonian mice"],"prefix":"10.1016","volume":"174","author":[{"given":"Nadhir","family":"Litim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Morissette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donatella","family":"Caruso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto C.","family":"Melcangi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Th\u00e9r\u00e8se","family":"Di Paolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Pt. 5","key":"10.1016\/j.jsbmb.2017.09.021_bib0005","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1093\/brain\/114.5.2283","article-title":"Ageing and Parkinson's disease: substantia nigra regional selectivity","volume":"114","author":"Fearnley","year":"1991","journal-title":"Brain"},{"issue":"Suppl. 1","key":"10.1016\/j.jsbmb.2017.09.021_bib0010","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1016\/S1353-8020(11)70018-9","article-title":"Neuronal vulnerability in Parkinson's disease","volume":"18","author":"Double","year":"2012","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.jsbmb.2017.09.021_bib0015","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1002\/mds.21475","article-title":"Levodopa-induced dyskinesias","volume":"22","author":"Fabbrini","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jsbmb.2017.09.021_bib0020","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0022-510X(73)90175-5","article-title":"Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations","volume":"20","author":"Bernheimer","year":"1973","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jsbmb.2017.09.021_bib0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/JPD-150769","article-title":"Retrograde axonal degeneration in Parkinson disease","volume":"6","author":"Tagliaferro","year":"2016","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.jsbmb.2017.09.021_bib0030","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.yfrne.2013.03.001","article-title":"Neurosteroid and neurotransmitter alterations in Parkinson's disease","volume":"34","author":"di Michele","year":"2013","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/j.jsbmb.2017.09.021_bib0035","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s00018-007-7403-5","article-title":"Neuroactive steroids: state of the art and new perspectives","volume":"65","author":"Melcangi","year":"2008","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.jsbmb.2017.09.021_bib0040","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jsbmb.2015.03.002","article-title":"New steps forward in the neuroactive steroid field","volume":"153","author":"Giatti","year":"2015","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2017.09.021_bib0045","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1038\/npp.2008.39","article-title":"Antipsychotic-like properties of 5-alpha-reductase inhibitors","volume":"33","author":"Bortolato","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jsbmb.2017.09.021_bib0050","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0006-3223(95)00101-8","article-title":"Sensorimotor gating in boys with Tourette's syndrome and ADHD: preliminary results","volume":"39","author":"Castellanos","year":"1996","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jsbmb.2017.09.021_bib0055","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1097\/JCP.0b013e3182549c2a","article-title":"Finasteride attenuates pathological gambling in patients with Parkinson disease","volume":"32","author":"Bortolato","year":"2012","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jsbmb.2017.09.021_bib0060","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.neuropharm.2015.05.015","article-title":"The 5alpha-reductase inhibitor Dutasteride but not Finasteride protects dopamine neurons in the MPTP mouse model of Parkinson's disease","volume":"97","author":"Litim","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jsbmb.2017.09.021_bib0065","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.neuropharm.2015.04.006","article-title":"Neuroprotection in Parkinsonian-treated mice via estrogen receptor alpha activation requires G protein-coupled estrogen receptor 1","volume":"95","author":"Bourque","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jsbmb.2017.09.021_bib0070","series-title":"The Mouse Brain in Stereotaxic Coordinates","author":"Franklin","year":"1997"},{"key":"10.1016\/j.jsbmb.2017.09.021_bib0075","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/syn.1067","article-title":"Neuroprotective properties of 17beta-estradiol, progesterone, and raloxifene in MPTP C57Bl\/6 mice","volume":"41","author":"Callier","year":"2001","journal-title":"Synapse"},{"key":"10.1016\/j.jsbmb.2017.09.021_bib0080","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/0969-8051(96)00023-6","article-title":"Effects of dopaminergic drug treatments on in vivo radioligand binding to brain vesicular monoamine transporters","volume":"23","author":"Kilbourn","year":"1996","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.jsbmb.2017.09.021_bib0085","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.neuropharm.2005.10.004","article-title":"ERbeta mediates the estradiol increase of D2 receptors in rat striatum and nucleus accumbens","volume":"50","author":"Le Saux","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jsbmb.2017.09.021_bib0090","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.neuropharm.2014.01.014","article-title":"Long-term treatment with l-DOPA and an mGlu5 receptor antagonist prevents changes in brain basal ganglia dopamine receptors, their associated signaling proteins and neuropeptides in parkinsonian monkeys","volume":"79","author":"Morin","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jsbmb.2017.09.021_bib0095","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/1098-2396(20000915)37:4<245::AID-SYN1>3.0.CO;2-5","article-title":"Stereospecific prevention by 17beta-estradiol of MPTP-induced dopamine depletion in mice","volume":"37","author":"Callier","year":"2000","journal-title":"Synapse"},{"key":"10.1016\/j.jsbmb.2017.09.021_bib0100","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0006-8993(95)00611-S","article-title":"Brain dopamine transporter: gender differences and effect of chronic haloperidol","volume":"692","author":"Rivest","year":"1995","journal-title":"Brain Res."},{"key":"10.1016\/j.jsbmb.2017.09.021_bib0105","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1016\/j.psyneuen.2013.04.016","article-title":"Comparison of plasma and cerebrospinal fluid levels of neuroactive steroids with their brain, spinal cord and peripheral nerve levels in male and female rats","volume":"38","author":"Caruso","year":"2013","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.jsbmb.2017.09.021_bib0110","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","article-title":"Parkinson's disease: mechanisms and models","volume":"39","author":"Dauer","year":"2003","journal-title":"Neuron"},{"issue":"Suppl. 3","key":"10.1016\/j.jsbmb.2017.09.021_bib0115","doi-asserted-by":"crossref","first-page":"S421","DOI":"10.1016\/S1353-8020(08)70041-5","article-title":"Positron emission tomography in premotor Parkinson's disease","volume":"13","author":"Stoessl","year":"2007","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.jsbmb.2017.09.021_bib0120","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1124\/pr.114.010397","article-title":"Regulation of the dopamine and vesicular monoamine transporters: pharmacological targets and implications for disease","volume":"67","author":"German","year":"2015","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.jsbmb.2017.09.021_bib0125","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0165-3806(94)90178-3","article-title":"Developmentally regulated glycosylation of dopamine transporter","volume":"83","author":"Patel","year":"1994","journal-title":"Brain Res. Dev. Brain Res."},{"key":"10.1016\/j.jsbmb.2017.09.021_bib0130","doi-asserted-by":"crossref","first-page":"21012","DOI":"10.1074\/jbc.M311972200","article-title":"The role of N-glycosylation in function and surface trafficking of the human dopamine transporter","volume":"279","author":"Li","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jsbmb.2017.09.021_bib0135","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.nbd.2009.09.002","article-title":"Dopamine transporter glycosylation correlates with the vulnerability of midbrain dopaminergic cells in Parkinson's disease","volume":"36","author":"Afonso-Oramas","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jsbmb.2017.09.021_bib0140","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.nbd.2010.07.012","article-title":"The dopamine transporter is differentially regulated after dopaminergic lesion","volume":"40","author":"Afonso-Oramas","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jsbmb.2017.09.021_bib0145","doi-asserted-by":"crossref","first-page":"e0153424","DOI":"10.1371\/journal.pone.0153424","article-title":"Restoration of the dopamine transporter through cell therapy improves dyskinesia in a rat model of Parkinson's disease","volume":"11","author":"Tomas","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jsbmb.2017.09.021_bib0150","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.nbd.2014.10.016","article-title":"Increased expression of the dopamine transporter leads to loss of dopamine neurons, oxidative stress and l-DOPA reversible motor deficits","volume":"74","author":"Masoud","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jsbmb.2017.09.021_bib0155","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.psyneuen.2015.09.014","article-title":"The neurosteroidogenic enzyme 5alpha-reductase modulates the role of D1 dopamine receptors in rat sensorimotor gating","volume":"63","author":"Frau","year":"2016","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.jsbmb.2017.09.021_bib0160","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.neuroscience.2012.12.058","article-title":"Estrogen receptors and lesion-induced response of striatal dopamine receptors","volume":"236","author":"Al Sweidi","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.jsbmb.2017.09.021_bib0165","first-page":"165","article-title":"Testosterone deficiency in a Parkinson's disease clinic: results of a survey","volume":"75","author":"Okun","year":"2004","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jsbmb.2017.09.021_bib0170","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1212\/01.WNL.0000106840.72938.84","article-title":"Plasma testosterone levels in Alzheimer and Parkinson diseases","volume":"62","author":"Okun","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.jsbmb.2017.09.021_bib0175","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1001\/archneur.59.11.1750","article-title":"Beneficial effects of testosterone replacement for the nonmotor symptoms of Parkinson disease","volume":"59","author":"Okun","year":"2002","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jsbmb.2017.09.021_bib0180","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/2054-7072-1-8","article-title":"Testosterone level and the effect of levodopa and agonists in early Parkinson disease: results from the INSPECT cohort","volume":"1","author":"Okun","year":"2014","journal-title":"J. Clin. Mov. Disord."},{"key":"10.1016\/j.jsbmb.2017.09.021_bib0185","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/ane.12334","article-title":"Prolactin and sex hormones levels in males with Parkinson's disease","volume":"131","author":"Nitkowska","year":"2015","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.jsbmb.2017.09.021_bib0190","doi-asserted-by":"crossref","first-page":"20843","DOI":"10.1074\/jbc.M112.443556","article-title":"Castration induces Parkinson disease pathologies in young male mice via inducible nitric-oxide synthase","volume":"288","author":"Khasnavis","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jsbmb.2017.09.021_bib0195","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1385\/ENDO:29:2:275","article-title":"Effects of age, gender, and gonadectomy on neurochemistry and behavior in animal models of Parkinson's disease","volume":"29","author":"Tamas","year":"2006","journal-title":"Endocrine"},{"key":"10.1016\/j.jsbmb.2017.09.021_bib0200","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1002\/mds.1170","article-title":"Hysterectomy, menopause, and estrogen use preceding Parkinson's disease: an exploratory case-control study","volume":"16","author":"Benedetti","year":"2001","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jsbmb.2017.09.021_bib0205","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1212\/01.wnl.0000280573.30975.6a","article-title":"Increased risk of parkinsonism in women who underwent oophorectomy before menopause","volume":"70","author":"Rocca","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.jsbmb.2017.09.021_bib0210","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1136\/jnnp.2006.103788","article-title":"Gender differences in Parkinson's disease","volume":"78","author":"Haaxma","year":"2007","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jsbmb.2017.09.021_bib0215","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.pjnns.2014.08.004","article-title":"Reproductive life characteristics in females affected with Parkinson's disease and in healthy control subjects \u2013 a comparative study on Polish population","volume":"48","author":"Nitkowska","year":"2014","journal-title":"Neurol. Neurochir. Pol."},{"key":"10.1016\/j.jsbmb.2017.09.021_bib0220","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1212\/WNL.62.11.2010","article-title":"Risk of Parkinson disease in women: effect of reproductive characteristics","volume":"62","author":"Ragonese","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.jsbmb.2017.09.021_bib0225","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1046\/j.1365-2826.2002.00833.x","article-title":"Lack of effect of testosterone and dihydrotestosterone compared to 17beta-oestradiol in 1-methyl-4-phenyl-1,2,3,6, tetrahydropyridine-mice","volume":"14","author":"Ekue","year":"2002","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.jsbmb.2017.09.021_bib0230","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0960-0760(94)90131-7","article-title":"Pharmacology of novel steroidal inhibitors of cytochrome P450(17) alpha (17 alpha-hydroxylase\/C17-20 lyase)","volume":"50","author":"Barrie","year":"1994","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2017.09.021_bib0235","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.pharmthera.2003.10.006","article-title":"The role of pregnane neurosteroids in ethanol withdrawal: behavioral genetic approaches","volume":"101","author":"Finn","year":"2004","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.jsbmb.2017.09.021_bib0240","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1159\/000438789","article-title":"Neuroprotective effect of progesterone in MPTP-treated male mice","volume":"103","author":"Bourque","year":"2016","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.jsbmb.2017.09.021_bib0245","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s12031-011-9570-y","article-title":"Modifications of neuroactive steroid levels in an experimental model of nigrostriatal degeneration: potential relevance to the pathophysiology of Parkinson's disease","volume":"46","author":"Melcangi","year":"2012","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.jsbmb.2017.09.021_bib0250","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1210\/en.2006-1678","article-title":"Steroid profiling in brain and plasma of male and pseudopregnant female rats after traumatic brain injury: analysis by gas chromatography\/mass spectrometry","volume":"148","author":"Meffre","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.jsbmb.2017.09.021_bib0255","doi-asserted-by":"crossref","first-page":"e50040","DOI":"10.1371\/journal.pone.0050040","article-title":"Allopregnanolone reinstates tyrosine hydroxylase immunoreactive neurons and motor performance in an MPTP-lesioned mouse model of Parkinson's disease","volume":"7","author":"Adeosun","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jsbmb.2017.09.021_bib0260","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/mds.26966","article-title":"Mitochondrial DNA and primary mitochondrial dysfunction in Parkinson's disease","volume":"32","author":"Giannoccaro","year":"2017","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jsbmb.2017.09.021_bib0265","doi-asserted-by":"crossref","first-page":"14602","DOI":"10.1073\/pnas.0606544103","article-title":"Characterization of brain neurons that express enzymes mediating neurosteroid biosynthesis","volume":"103","author":"Agis-Balboa","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jsbmb.2017.09.021_bib0270","first-page":"25","article-title":"Hydroxysteroid 17-beta dehydrogenase type 10 disease in siblings","volume":"32","author":"Richardson","year":"2017","journal-title":"JIMD Rep."},{"key":"10.1016\/j.jsbmb.2017.09.021_bib0275","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.jsbmb.2014.07.001","article-title":"Roles of 17beta-hydroxysteroid dehydrogenase type 10 in neurodegenerative disorders","volume":"143","author":"Yang","year":"2014","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2017.09.021_bib0280","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s10545-011-9415-4","article-title":"HSD10 disease: clinical consequences of mutations in the HSD17B10 gene","volume":"35","author":"Zschocke","year":"2012","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.jsbmb.2017.09.021_bib0285","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1093\/hmg\/ddu072","article-title":"Mutation or knock-down of 17beta-hydroxysteroid dehydrogenase type 10 cause loss of MRPP1 and impaired processing of mitochondrial heavy strand transcripts","volume":"23","author":"Deutschmann","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jsbmb.2017.09.021_bib0290","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/emmm.200900055","article-title":"A non-enzymatic function of 17beta-hydroxysteroid dehydrogenase type 10 is required for mitochondrial integrity and cell survival","volume":"2","author":"Rauschenberger","year":"2010","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.jsbmb.2017.09.021_bib0295","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/ana.20133","article-title":"L-3-hydroxyacyl-CoA dehydrogenase II protects in a model of Parkinson's disease","volume":"56","author":"Tieu","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jsbmb.2017.09.021_bib0300","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1038\/cdd.2014.224","article-title":"Parkin maintains mitochondrial levels of the protective Parkinson's disease-related enzyme 17-beta hydroxysteroid dehydrogenase type 10","volume":"22","author":"Bertolin","year":"2015","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.jsbmb.2017.09.021_bib0305","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.brainres.2008.06.116","article-title":"MPTP-induced Parkinsonism is associated with damage to Leydig cells and testosterone loss","volume":"1229","author":"Ruffoli","year":"2008","journal-title":"Brain Res."},{"key":"10.1016\/j.jsbmb.2017.09.021_bib0310","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1097-2765(00)80408-6","article-title":"Mammalian microsomal cytochrome P450 monooxygenase: structural adaptations for membrane binding and functional diversity","volume":"5","author":"Williams","year":"2000","journal-title":"Mol. Cell"},{"key":"10.1016\/j.jsbmb.2017.09.021_bib0315","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3389\/fnmol.2017.00187","article-title":"The endoplasmic reticulum unfolded protein response in neurodegenerative disorders and its potential therapeutic significance","volume":"10","author":"Remondelli","year":"2017","journal-title":"Front. Mol. Neurosci"},{"key":"10.1016\/j.jsbmb.2017.09.021_bib0320","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1527-3458.2006.00053.x","article-title":"A new look at the 5alpha-reductase inhibitor finasteride","volume":"12","author":"Finn","year":"2006","journal-title":"CNS Drug Rev."},{"key":"10.1016\/j.jsbmb.2017.09.021_bib0325","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/0006-8993(94)91731-0","article-title":"Progesterone 5-alpha-reduction in neuronal and in different types of glial cell cultures: type 1 and 2 astrocytes and oligodendrocytes","volume":"639","author":"Melcangi","year":"1994","journal-title":"Brain Res."},{"key":"10.1016\/j.jsbmb.2017.09.021_bib0330","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.psyneuen.2012.06.008","article-title":"Regional distribution of 5alpha-reductase type 2 in the adult rat brain: an immunohistochemical analysis","volume":"38","author":"Castelli","year":"2013","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.jsbmb.2017.09.021_bib0335","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1210\/en.2016-1316","article-title":"Profiling neuroactive steroid levels after traumatic brain injury in male mice","volume":"157","author":"Lopez-Rodriguez","year":"2016","journal-title":"Endocrinology"},{"key":"10.1016\/j.jsbmb.2017.09.021_bib0340","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1159\/000442982","article-title":"Effects of subchronic finasteride treatment and withdrawal on neuroactive steroid levels and their receptors in the male rat brain","volume":"103","author":"Giatti","year":"2016","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.jsbmb.2017.09.021_bib0345","doi-asserted-by":"crossref","first-page":"4072","DOI":"10.1158\/1078-0432.CCR-06-0184","article-title":"Pharmacologic basis for the enhanced efficacy of dutasteride against prostatic cancers","volume":"12","author":"Xu","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jsbmb.2017.09.021_bib0350","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S1474-4422(09)70062-6","article-title":"Neuroinflammation in Parkinson's disease: a target for neuroprotection?","volume":"8","author":"Hirsch","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jsbmb.2017.09.021_bib0355","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/ncpneuro0355","article-title":"Mechanisms of Disease: astrocytes in neurodegenerative disease","volume":"2","author":"Maragakis","year":"2006","journal-title":"Nat. Clin. Pract. Neurol."},{"issue":"Suppl. 3","key":"10.1016\/j.jsbmb.2017.09.021_bib0360","first-page":"13","article-title":"Role of inflammatory factors in neurodegeneration","volume":"35","author":"Czlonkowska","year":"2001","journal-title":"Neurol. Neurochir. Pol."},{"key":"10.1016\/j.jsbmb.2017.09.021_bib0365","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3109\/00207450108986528","article-title":"Astroglial and microglial reaction after a partial nigrostriatal degeneration induced by the striatal injection of different doses of 6-hydroxydopamine","volume":"109","author":"Rodrigues","year":"2001","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.jsbmb.2017.09.021_bib0370","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1002\/jnr.21325","article-title":"Neuroinflammation and regulation of glial glutamate uptake in neurological disorders","volume":"85","author":"Tilleux","year":"2007","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.jsbmb.2017.09.021_bib0375","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/BF03191116","article-title":"Anti-nociceptive and anti-inflammatory properties of 5alpha-reductase inhibitor finasteride in experimental animals","volume":"33","author":"Duborija-Kovacevic","year":"2008","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.jsbmb.2017.09.021_bib0380","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.yhbeh.2007.02.008","article-title":"Finasteride, a 5alpha-reductase inhibitor, potentiates antinociceptive effects of morphine, prevents the development of morphine tolerance and attenuates abstinence behavior in the rat","volume":"51","author":"Verdi","year":"2007","journal-title":"Horm. Behav."},{"key":"10.1016\/j.jsbmb.2017.09.021_bib0385","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1021\/pr700686x","article-title":"A connection between the mitochondrial permeability transition pore, autophagy, and cerebral amyloidogenesis","volume":"7","author":"Soskic","year":"2008","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.jsbmb.2017.09.021_bib0390","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1124\/mol.105.018671","article-title":"Implication of the phosphatidylinositol-3 kinase\/protein kinase B signaling pathway in the neuroprotective effect of estradiol in the striatum of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice","volume":"69","author":"D'Astous","year":"2006","journal-title":"Mol. Pharmacol."}],"container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076017302698?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076017302698?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T23:55:41Z","timestamp":1760745341000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960076017302698"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":78,"alternative-id":["S0960076017302698"],"URL":"https:\/\/doi.org\/10.1016\/j.jsbmb.2017.09.021","relation":{},"ISSN":["0960-0760"],"issn-type":[{"value":"0960-0760","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of the 5\u03b1-reductase enzyme inhibitor dutasteride in the brain of intact and parkinsonian mice","name":"articletitle","label":"Article Title"},{"value":"The Journal of Steroid Biochemistry and Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsbmb.2017.09.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}